HCW Biologics Inc.
Hedge Funds Holdings
Last updated:
HCW Biologics Inc.‘s stocks are currently a part of 7 hedge funds’ portfolios, which represents 1.19% of the total amount of its stocks outstanding. This makes up a total of 425.56K shares of HCW Biologics Inc.. Compared to the previous quarter, the number fell by -45.51% or -355.45K shares fewer. As for the holding position changes, 57.14% (4) of current hedge fund investors increased the number of shares held, 14.29% (1) of current holders sold a part of the shares held, and 14.29% (1) closed the holdings completely.
Hedge funds holding HCW Biologics (Q3 2021 – Q1 2023)
| Q3 2021 | 8 |
|---|---|
| Q4 2021 | 11 |
| Q1 2022 | 12 |
| Q2 2022 | 12 |
| Q3 2022 | 11 |
| Q4 2022 | 14 |
| Q1 2023 | 7 |
Hedge funds changes in HCW Biologics positions (Q3 2021 – Q1 2023)
| Q3 2021 | 8 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2021 | 7 | 2 | 1 | 4 | -3 |
| Q1 2022 | 2 | 6 | 1 | 1 | 2 |
| Q2 2022 | 0 | 8 | 1 | 0 | 3 |
| Q3 2022 | 0 | 4 | 2 | 1 | 4 |
| Q4 2022 | 3 | 4 | 2 | 0 | 5 |
| Q1 2023 | 0 | 4 | 1 | 1 | 1 |
Top 50 hedge fund holders of HCW Biologics Inc. (NASDAQ:HCWB)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| HIGHTOWER ADVISORS, LLC | 517K | 225.59K | 0.001% |
| GEODE CAPITAL MANAGEMENT, LLC | 300K | 131.31K | 0.000% |
| VANGUARD GROUP INC | 218K | 95.39K | 0.000% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 166K | 72.6K | 0.004% |
| BLACKROCK INC. Larry Fink | 96K | 41.69K | 0.000% |
| TWO SIGMA INVESTMENTS, LP John Overdeck | 87K | 38.04K | 0.000% |
| STATE STREET CORP | 49K | 21.44K | 0.000% |
| CRESSET ASSET MANAGEMENT, LLC | 40K | 17.56K | 0.001% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 15K | 6.42K | 0.000% |
| MORGAN STANLEY | 8K | 3.40K | 0.000% |
| FOCUSED WEALTH MANAGEMENT, INC | 2K | 1K | 0.000% |
| UBS GROUP AG | 0 | 0 | 0.000% |